Press release
Global Trastuzumab Biosimilar Market is Expected to Grow at Rapid Pace With Strong Presence of Major Players such as Amgen Inc., Biocon Limited, Mylan Inc., BioXpress Therapeutics SA, Celltrion, Teva Pharmaceutical Industries Ltd., Apotex Inc., Pfizer Inc
Trastuzumab is marketed under the trade/brand name of Herceptin. It is developed by F. Hoffmann-La Roche AG and was approved by U.S Food Drug Administration (FDA) in 1998 and by European Medicines Agency in 2000. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). It is also approved for the treatment of HER2 positive breast cancer as well as it is also approved for the treatment of metastatic breast cancer and gastric cancer. Patent of Herceptin expired in Europe in 2014, in Asia in 2017, and in the U.S. the patent will expire in 2019.
Samsung Bioepis announced the launch of first biosimilar for trastuzumab i.e Ontruzant in Europe on November 2017, thus entry of biosimilar into the market have boosted the growth of trastuzumab biosimilar market.
Request for ToC/Proposal: https://bit.ly/2XhOLc1
The trastuzumab biosimilar market is fragmented/consolidated with presence of many/few players that operates in local as well as international market.
Global trastuzumab biosimilar Market reports cover prominent players like Amgen Inc., Biocon Limited, Mylan Inc., BioXpress Therapeutics SA, Celltrion, Teva Pharmaceutical Industries Ltd., Apotex Inc., Pfizer Inc., AryoGen Pharmed, Samsung BioepisCo., Ltd., and Merck & Co.
Curious about this latest version of report?
Obtain Report Details @ https://bit.ly/2XhOLc1
Market Segments
• Global Trastuzumab Biosimilar Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Application
o Breast Cancer
o Gastric Cancer
o Other
• Global Trastuzumab Biosimilar Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Distribution Channel
o Hospital Pharmacy
o Online Pharmacy
o Retail Pharmacy
o Other Direct Distribution Channels
Why should buy this report:
To receive a comprehensive analysis of the prospects for global trastuzumab biosimilar market
To receive industry overview and future trends trastuzumab biosimilar market
To analyze the trastuzumab biosimilar market drivers and challenges
To get information on trastuzumab biosimilar market size and forecast
To get details on trastuzumab biosimilar clinical trial/pipeline analysis
Originator drug historic revenue
Originator drug key news/industry activities
Major Mergers & Acquisition in trastuzumab biosimilar industry
For More Information @ https://bit.ly/2XhOLc1
Mr. John Smith
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ https://bit.ly/2EgGlWR
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Trastuzumab Biosimilar Market is Expected to Grow at Rapid Pace With Strong Presence of Major Players such as Amgen Inc., Biocon Limited, Mylan Inc., BioXpress Therapeutics SA, Celltrion, Teva Pharmaceutical Industries Ltd., Apotex Inc., Pfizer Inc here
News-ID: 1785737 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Trastuzumab
Rising Breast And Gastric Cancer Prevalence Drives Trastuzumab Biosimilars Marke …
"The Trastuzumab Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Trastuzumab Biosimilars Market Size and Projected Growth Rate?
The trastuzumab biosimilars market has seen rapid growth in recent years. It will grow from $4.27 billion in 2024 to $5.43 billion in 2025,…
Leading Growth Driver in the Trastuzumab Biosimilars Market in 2025: Rising Brea …
What Are the Market Size and Growth Forecast for the Trastuzumab Biosimilars Market?
The market for trastuzumab biosimilars has witnessed significant expansion in the past few years. The market is projected to increase from $4.27 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 27.1%. The historical growth patterns can be attributed to the expansion and globalization of the market, expiry of patents and…
Leading Growth Driver in the Trastuzumab Biosimilars Market in 2025: Rising Brea …
What Are the Market Size and Growth Forecast for the Trastuzumab Biosimilars Market?
The market for trastuzumab biosimilars has witnessed significant expansion in the past few years. The market is projected to increase from $4.27 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 27.1%. The historical growth patterns can be attributed to the expansion and globalization of the market, expiry of patents and…
Herceptin (Trastuzumab) Market Overview,Recent Devolopment And Forecast During ( …
This report presents an overview of global market for Herceptin (Trastuzumab), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Herceptin (Trastuzumab), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Herceptin (Trastuzumab), and key regions/countries of…
Trastuzumab Biosimilar Market Opportunities and Growth Challenges Report 2022-20 …
Global Trastuzumab Biosimilar Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis
Trastuzumab Biosimilar Market Overview
The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Trastuzumab Biosimilar Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as the…
Trastuzumab Biosimilar Market 2022 | Detailed Report
According to Market Study Report, Trastuzumab Biosimilar Market provides a comprehensive analysis of the Trastuzumab Biosimilar Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5511273
The report provides a comprehensive analysis of company profiles listed below:
- Amgen Inc.
- Pfizer Inc
- Samsung Bioepis
-…
